FDA
-
-
-
-
-
-
-
HCW Biologics and WY Biotech Announce Closing of First Round of Financing For Newly Formed Joint Venture Trimmune
-
-
-
-
-
-
-
HCW Biologics to Showcase its Novel Second-Generation Immune Checkpoint Inhibitor Identified as a Potential Gateway to a Multi-Billion Dollar Market
-
-
-
-
-
-
-
HCW Biologics (HCWB) announces 1-for-40 reverse stock split to regain Nasdaq compliance
-
-
-
-
-
-
-
HCW Biologics Reports Second Quarter 2024 Financial Results and Business Highlights
-
-
-
-
-
-
-
HCW Biologics Reports First Quarter 2022 Financial Results and Recent Business Highlights
-
-
-
-
-
-
-
HCW Biologics Reports Fourth Quarter and Full Year 2021 Financial Results and Business Highlights for 2021
-
-
-
-
-
-
-
HCW Biologics Inc. Announces its Lead Product Candidate Shown to Augment Anti-Tumor Activity and Reduce Side Effects of Chemotherapy Regimens
-
330,674 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

